Moreover, as PI3K mutation and PTEN inactivation have been shown to be the causes of resistance to other targeted cancer therapies [26], the PI3K may even circumvent drug resistance to current chemotherapy in combination with other anticancer drugs [27]. This evidence concerns the gene PIK3CD and cancer.